prednisolone has been researched along with Alopecia Circumscripta in 29 studies
Prednisolone: A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states.
prednisolone : A glucocorticoid that is prednisone in which the oxo group at position 11 has been reduced to the corresponding beta-hydroxy group. It is a drug metabolite of prednisone.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Placebo-controlled studies with varying dosage schedules are required to standardize the dose of prednisolone used in pulse therapy, optimize the therapeutic efficacy, and minimize side effects." | 6.71 | Placebo-controlled oral pulse prednisolone therapy in alopecia areata. ( Dogra, S; Handa, S; Kar, BR; Kumar, B, 2005) |
| "Several treatments for alopecia areata including administration of systemic prednisolone were attempted, but loss of hair on the scalp progressed." | 5.30 | Alopecia areata associated with myasthenia gravis and thymoma: a case of alopecia with marked improvement following thymectomy and high level prednisolone administration. ( Hatamochi, A; Kamada, N; Shinkai, H, 1997) |
| "Patients with widespread alopecia (> 40% scalp involvement), including alopecia totalis (AT) and universalis (AU), were treated with 300 mg oral prednisolone pulses at 4-week intervals, for a minimum of 4 doses or until cosmetically acceptable hair growth was obtained." | 3.69 | Pulsed administration of corticosteroids in the treatment of alopecia areata. ( Sharma, VK, 1996) |
| "Severe extensive alopecia areata (totalis) was treated with prednisolone as a single 2 g dose i." | 3.65 | Large doses of glucocorticoid in the treatment of alopecia areata. ( Burton, JL; Shuster, S, 1975) |
| "To assess the benefits and harms of the treatments for alopecia areata (AA), alopecia totalis (AT), and alopecia universalis (AU) in children and adults." | 3.01 | Treatments for alopecia areata: a network meta-analysis. ( Bennouna-Dalero, T; Correa-Pérez, A; Fernández-García, S; Gaetano Gil, A; Giraldo, L; Mateos-Haro, M; Novoa-Candia, M; Ortega-Quijano, D; Saceda-Corralo, D; Sánchez Vanegas, G; Tomlinson, J; Urueña Rodriguez, MG; Vaño-Galván, S; Zamora, J, 2023) |
| "Alopecia areata is a world wide cosmetic problem." | 2.73 | Efficacy of combination therapy for the management regime of Alopecia areata. ( Chowdhury, MM; Rahman, MH; Wahab, MA, 2007) |
| " After the treatment, each treatment modality was evaluated by the response rate, relapse rate, and side effect profile." | 2.72 | A comparison of the efficacy, relapse rate and side effects among three modalities of systemic corticosteroid therapy for alopecia areata. ( Aiba, S; Kawamura, M; Kurosawa, M; Mizuashi, M; Nakagawa, S; Saito, M; Sasaki, Y, 2006) |
| " Placebo-controlled studies with varying dosage schedules are required to standardize the dose of prednisolone used in pulse therapy, optimize the therapeutic efficacy, and minimize side effects." | 2.71 | Placebo-controlled oral pulse prednisolone therapy in alopecia areata. ( Dogra, S; Handa, S; Kar, BR; Kumar, B, 2005) |
| "Cronkhite-Canada syndrome is an acquired inflammatory polyposis syndrome in which alopecia, onychomadesis and hyperpigmentation occur concurrently with gastrointestinal symptoms." | 1.46 | Alopecia areata incognita in Cronkhite-Canada syndrome. ( Carton, J; Grabczynska, S; Kubba, F; Ong, S; Osborn, M; Rodriguez-Garcia, C; Stefanato, CM; Walters, J, 2017) |
| "Several treatments for alopecia areata including administration of systemic prednisolone were attempted, but loss of hair on the scalp progressed." | 1.30 | Alopecia areata associated with myasthenia gravis and thymoma: a case of alopecia with marked improvement following thymectomy and high level prednisolone administration. ( Hatamochi, A; Kamada, N; Shinkai, H, 1997) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 10 (34.48) | 18.7374 |
| 1990's | 4 (13.79) | 18.2507 |
| 2000's | 6 (20.69) | 29.6817 |
| 2010's | 8 (27.59) | 24.3611 |
| 2020's | 1 (3.45) | 2.80 |
| Authors | Studies |
|---|---|
| Mateos-Haro, M | 1 |
| Novoa-Candia, M | 1 |
| Sánchez Vanegas, G | 1 |
| Correa-Pérez, A | 1 |
| Gaetano Gil, A | 1 |
| Fernández-García, S | 1 |
| Ortega-Quijano, D | 1 |
| Urueña Rodriguez, MG | 1 |
| Saceda-Corralo, D | 1 |
| Bennouna-Dalero, T | 1 |
| Giraldo, L | 1 |
| Tomlinson, J | 1 |
| Vaño-Galván, S | 1 |
| Zamora, J | 1 |
| Christensen, A | 1 |
| Ashokan, A | 1 |
| Gordon, DL | 1 |
| Lai, VWY | 1 |
| Chen, G | 1 |
| Gin, D | 1 |
| Sinclair, R | 1 |
| Abdel Halim, D | 1 |
| Abu Zeid, OM | 1 |
| Rashed, L | 1 |
| Saleh, MA | 1 |
| Horikawa, H | 1 |
| Hirai, I | 1 |
| Umegaki-Arao, N | 1 |
| Amagai, M | 1 |
| Saito, M | 2 |
| Saito-Shono, T | 1 |
| Ito, A | 1 |
| Hatano, Y | 1 |
| Kumagi, M | 1 |
| Ishii, K | 1 |
| Fujiwara, S | 1 |
| Sankararaman, S | 1 |
| Bobonich, M | 1 |
| Aktay, AN | 1 |
| Ong, S | 1 |
| Rodriguez-Garcia, C | 1 |
| Grabczynska, S | 1 |
| Carton, J | 1 |
| Osborn, M | 1 |
| Walters, J | 1 |
| Kubba, F | 1 |
| Stefanato, CM | 1 |
| Jahn-Bassler, K | 1 |
| Bauer, WM | 1 |
| Karlhofer, F | 1 |
| Vossen, MG | 1 |
| Stingl, G | 1 |
| LUBOWE, II | 1 |
| RISSE-SUNDERMANN, A | 1 |
| Bunker, CB | 1 |
| Kar, BR | 1 |
| Handa, S | 1 |
| Dogra, S | 1 |
| Kumar, B | 1 |
| Nakamura, M | 1 |
| Miyachi, Y | 1 |
| Sladden, MJ | 1 |
| Hutchinson, PE | 1 |
| Kurosawa, M | 1 |
| Nakagawa, S | 1 |
| Mizuashi, M | 1 |
| Sasaki, Y | 1 |
| Kawamura, M | 1 |
| Aiba, S | 1 |
| Chowdhury, MM | 1 |
| Rahman, MH | 1 |
| Wahab, MA | 1 |
| Wakata, N | 1 |
| Sumiyoshi, S | 1 |
| Tagaya, N | 1 |
| Okada, S | 1 |
| Araki, Y | 1 |
| Kinoshita, M | 1 |
| Sharma, VK | 1 |
| Kubota, A | 1 |
| Komiyama, A | 1 |
| Hasegawa, O | 1 |
| Kamada, N | 1 |
| Hatamochi, A | 1 |
| Shinkai, H | 1 |
| Burton, JL | 1 |
| Shuster, S | 1 |
| Butenandt, O | 1 |
| Thompson, DM | 1 |
| Robinson, TW | 1 |
| Lennard-Jones, J | 1 |
| Lehnert, W | 1 |
| Vinokurov, IN | 1 |
| Husmann, F | 1 |
| Kaffarnik, H | 1 |
| Belezos, NK | 1 |
| Kononenko, OG | 1 |
| Iudkina, LN | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| The Comparison Study of Intralesional Botulinum Toxin A and Corticosteroid Injection for Alopecia Areata[NCT00999869] | 20 participants (Anticipated) | Interventional | 2009-11-30 | Recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 reviews available for prednisolone and Alopecia Circumscripta
| Article | Year |
|---|---|
Treatments for alopecia areata: a network meta-analysis.
Topics: Adolescent; Adult; Aged; Alopecia Areata; Betamethasone; Biological Products; Child; Child, Preschoo | 2023 |
Systemic treatments for alopecia areata: A systematic review.
Topics: Adjuvants, Immunologic; Administration, Intravenous; Administration, Oral; Alopecia; Alopecia Areata | 2019 |
3 trials available for prednisolone and Alopecia Circumscripta
| Article | Year |
|---|---|
Placebo-controlled oral pulse prednisolone therapy in alopecia areata.
Topics: Administration, Oral; Adolescent; Adult; Alopecia Areata; Autoimmune Diseases; Drug Administration S | 2005 |
A comparison of the efficacy, relapse rate and side effects among three modalities of systemic corticosteroid therapy for alopecia areata.
Topics: Administration, Oral; Adolescent; Adult; Alopecia Areata; Anti-Inflammatory Agents; Dexamethasone; D | 2006 |
Efficacy of combination therapy for the management regime of Alopecia areata.
Topics: Adult; Alopecia Areata; Anti-Inflammatory Agents; Bangladesh; Drug Therapy, Combination; Female; Hum | 2007 |
24 other studies available for prednisolone and Alopecia Circumscripta
| Article | Year |
|---|---|
A rash diagnosis.
Topics: Alopecia Areata; Anti-Bacterial Agents; Diagnosis, Differential; Exanthema; Humans; Male; Middle Age | 2017 |
Alteration of serum and tissue tumor necrosis factor alpha levels: A possible mechanism of action of oral pulse steroids in the treatment of alopecia areata.
Topics: Administration, Oral; Adolescent; Adult; Alopecia Areata; Biopsy; Case-Control Studies; Female; Gluc | 2019 |
Alopecia in Cronkhite-Canada syndrome: Is it truly telogen effluvium?
Topics: Administration, Oral; Alopecia Areata; Biopsy, Needle; Dermoscopy; Endoscopy, Gastrointestinal; Huma | 2019 |
Case of alopecia areata accompanied by polymyalgia rheumatica.
Topics: Alopecia Areata; Glucocorticoids; Humans; Male; Middle Aged; Polymyalgia Rheumatica; Prednisolone | 2015 |
Alopecia Areata in an Adolescent With Inflammatory Bowel Disease.
Topics: Adolescent; Alopecia Areata; Child; Female; Glucocorticoids; Humans; Immunosuppressive Agents; Infla | 2017 |
Alopecia areata incognita in Cronkhite-Canada syndrome.
Topics: Alopecia Areata; Anti-Inflammatory Agents, Non-Steroidal; Female; Glucocorticoids; Humans; Intestina | 2017 |
Kombinierte Hoch-/Niedrig-Dosis-Therapie mit systemischen Glukokor-tikoiden bei schweren Verlaufsformen der Alopecia areata im Kindesalter.
Topics: Acne Vulgaris; Adolescent; Alopecia Areata; Austria; Body Weight; Child; Child, Preschool; Cushing S | 2017 |
Alopecia.
Topics: Alopecia; Alopecia Areata; Humans; Prednisolone | 1959 |
[Intradermal injections of microcrystallized prednisolone trimethylacetate in alopecia areata].
Topics: Alopecia; Alopecia Areata; Humans; Injections, Intradermal; Prednisolone | 1960 |
Systemic steroids in the treatment of alopecia areata.
Topics: Administration, Oral; Alopecia Areata; Glucocorticoids; Humans; Injections, Intramuscular; Prednisol | 2004 |
Two cases of alopecia areata associated with Takayasu arteritis.
Topics: Adult; Alopecia Areata; Dose-Response Relationship, Drug; Female; Glucocorticoids; Humans; Prednisol | 2004 |
Is oral pulsed prednisolone useful in alopecia areata? Critical appraisal of a randomized trial.
Topics: Administration, Oral; Alopecia Areata; Glucocorticoids; Humans; Prednisolone; Randomized Controlled | 2005 |
A case of myasthenia gravis accompanied by invasive thymoma, alopecia areata and dry mouth.
Topics: Adult; Alopecia Areata; Edrophonium; Humans; Immune System Diseases; Magnetic Resonance Imaging; Mal | 1995 |
Pulsed administration of corticosteroids in the treatment of alopecia areata.
Topics: Administration, Oral; Adolescent; Adult; Alopecia; Alopecia Areata; Drug Administration Schedule; Es | 1996 |
Myasthenia gravis and alopecia areata.
Topics: Adolescent; Adult; Aged; Alopecia Areata; Child; Child, Preschool; Female; Humans; Infant; Male; Mid | 1997 |
Alopecia areata associated with myasthenia gravis and thymoma: a case of alopecia with marked improvement following thymectomy and high level prednisolone administration.
Topics: Alopecia Areata; Combined Modality Therapy; Female; Follow-Up Studies; Glucocorticoids; Humans; Midd | 1997 |
Large doses of glucocorticoid in the treatment of alopecia areata.
Topics: Administration, Oral; Adolescent; Adult; Aged; Alopecia Areata; Female; Humans; Injections, Intraven | 1975 |
[High-dose glucocorticoid therapy of total alopecia areata].
Topics: Alopecia Areata; Child; Humans; Prednisolone | 1979 |
Alopecia areata, vitiligo, scleroderma and ulcerative colitis.
Topics: Adult; Alopecia Areata; Barium Sulfate; Colitis, Ulcerative; Enema; Humans; Lichen Planus; Male; Pre | 1974 |
[Local therapy of severe forms of alopecia areata with corticosteroid ointments].
Topics: Administration, Topical; Adolescent; Adult; Alopecia Areata; Anti-Inflammatory Agents; Female; Follo | 1974 |
[Current methods of therapy in alopecia areata].
Topics: 17-Hydroxycorticosteroids; 17-Ketosteroids; Adult; Alopecia Areata; Female; Humans; Male; Middle Age | 1968 |
[On the corticosteroid therapy of alopecia areata].
Topics: Adult; Alopecia Areata; Humans; Male; Prednisolone; Prednisone | 1965 |
Local estrogen and ultraviolet irradiation in the treatment of total alopecia (areata).
Topics: Administration, Topical; Adult; Alopecia Areata; Anti-Inflammatory Agents; Child; Endocrine System D | 1965 |
[Combined treatment of patients with alopecia areata and total alopecia by using corticosteroid drugs orally and topically].
Topics: Alopecia; Alopecia Areata; Anti-Inflammatory Agents; Humans; Prednisolone; Prednisone | 1965 |